Thermo Fisher Scientific Inc (TMO)

TMO on New York Consolidated

128.45USD
19 Dec 2014
Price Change (% chg)

$0.93 (+0.73%)
Prev Close
$127.52
Open
$127.16
Day's High
$129.29
Day's Low
$127.07
Volume
3,121,010
Avg. Vol
1,944,588
52-wk High
$129.77
52-wk Low
$105.93

TMO

Chart for TMO

About

Thermo Fisher Scientific Inc. (Thermo Fisher) is engaged in serving science. The Company operates in three segments: Analytical Technologies, Specialty Diagnostics and Laboratory Products and Services. The Company serves its customers through three brands: Thermo Scientific, Fisher Scientific and Unity Lab Services. Thermo... (more)

Overall

Beta: 0.94
Market Cap (Mil.): $51,383.27
Shares Outstanding (Mil.): 400.03
Dividend: 0.15
Yield (%): 0.47

Financials

  TMO Industry Sector
P/E (TTM): 31.01 32.43 38.47
EPS (TTM): 4.14 -- --
ROI: 5.25 8.00 18.25
ROE: 8.85 12.91 19.13
Search Stocks

Fitch Rates Thermo Fisher's EUR Snr Notes 'BBB'; Outlook Negative

(The following statement was released by the rating agency) NEW YORK, November 17 (Fitch) Fitch Ratings has assigned a 'BBB' rating to Thermo Fisher Scientific's (Thermo Fisher) Euro denominated 640 million senior notes. The Rating Outlook is Negative. The ratings apply to $14.5 billion of debt at Sept. 27, 2014. A full list of ratings follows at the end of this press release. Along with $800 million of senior notes issued earlier this month, the proceeds of the Euro denominated issue will

17 Nov 2014

Fitch Rates Thermo Fisher's Proposed Notes 'BBB'; Outlook Remains Negative

(The following statement was released by the rating agency) NEW YORK, November 06 (Fitch) Fitch Ratings has assigned a 'BBB' rating to Thermo Fisher Scientific's (Thermo Fisher) proposed $800 million senior notes. The Rating Outlook is Negative. The ratings apply to $14.5 billion of debt at Sept. 27, 2014. A full list of ratings follows at the end of this press release. The proceeds of the proposed notes will be used to fund a portion of $3.1 billion of scheduled debt maturities in the nex

06 Nov 2014

Late-summer 2015 too late for rate hike: Fed's Fisher

NEW YORK - Raising the U.S. Federal Reserve's key interest rate in late-summer of 2015, as financial markets generally expect, would be waiting too long, Dallas Fed President Richard Fisher said on Monday.

03 Nov 2014

Late-summer 2015 too late for rate hike -Fed's Fisher

NEW YORK, Nov 3 - Raising the U.S. Federal Reserve's key interest rate in late-summer of 2015, as financial markets generally expect, would be waiting too long, Dallas Fed President Richard Fisher said on Monday.

03 Nov 2014

Thermo Fisher pledges to fix glitch in drug analysis software

LONDON - Thermo Fisher Scientific has pledged to correct a glitch in software used to analyze data from clinical drug trials within "four to eight weeks", after independent experts highlighted a potential for errors.

03 Nov 2014

Thermo Fisher pledges to fix glitch in drug analysis software

LONDON, Nov 3 - Thermo Fisher Scientific has pledged to correct a glitch in software used to analyse data from clinical drug trials within "four to eight weeks", after independent experts highlighted a potential for errors.

03 Nov 2014

Thermo Fisher profit jumps but revenue disappoints, shares drop

- Thermo Fisher Scientific Inc , said quarterly profit rose nearly 49 percent, boosted by the acquisition of genetic testing company Life Technologies, but shares fell 3 percent as revenue growth disappointed investors.

22 Oct 2014

UPDATE 1-Thermo Fisher profit jumps but revenue disappoints, shares drop

(New throughout, updates share price, adds details and analyst comments)

22 Oct 2014

Thermo Fisher profit jumps as Life Tech buyout pays off

Oct 22 - Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, reported an about 49 percent rise in quarterly profit as it benefited from the acquisition of genetic testing company Life Technologies.

22 Oct 2014

BRIEF-Thermo Fisher Scientific Q3 adjusted earnings per share $1.71

* Q3 earnings per share $1.17; Q3 adjusted earnings per share $1.71; Q3 revenue up 31 percent to $4.17 billion

22 Oct 2014

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks